NCT07306832
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07306832
Title A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: child
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Lucile Packard Children's Hospital /ID# 276015 RECRUITING Palo Alto California 94304 United States Details
New York Medical College /ID# 275597 RECRUITING Valhalla New York 10595 United States Details
Tristar Centennial Medical Center /ID# 275831 RECRUITING Nashville Tennessee 37203 United States Details
Perth Children'S Hospital /ID# 275673 RECRUITING Perth Western Australia 6009 Australia Details
Seoul National University Hospital /ID# 276978 RECRUITING Seoul Seoul Teugbyeolsi 03080 South Korea Details
Samsung Medical Center /ID# 276979 RECRUITING Seoul Seoul Teugbyeolsi 06351 South Korea Details
National Taiwan University Hospital /ID# 276635 RECRUITING Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field